Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas

Frequent mutations in isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) and the promoter of telomerase reverse transcriptase (TERT) represent two significant discoveries in glioma genomics. Understanding the degree to which these two mutations co-occur or occur exclusively of one another in glioma su...

Descripción completa

Detalles Bibliográficos
Autores principales: Killela, Patrick J., Pirozzi, Christopher J., Healy, Patrick, Reitman, Zachary J., Lipp, Eric, Rasheed, B. Ahmed, Yang, Rui, Diplas, Bill H., Wang, Zhaohui, Greer, Paula K., Zhu, Huishan, Wang, Catherine Y., Carpenter, Austin B., Friedman, Henry, Friedman, Allan H., Keir, Stephen T., He, Jie, He, Yiping, McLendon, Roger E., Herndon II, James E., Yan, Hai, Bigner, Darell D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4039228/
https://www.ncbi.nlm.nih.gov/pubmed/24722048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4039228/
https://www.ncbi.nlm.nih.gov/pubmed/24722048

Ejemplares similares